A novel nomogram individually predicting disease‐specific survival after D2 gastrectomy for advanced gastric cancer

Abstract

The established nomogram was able to predict 3-, 5-, and 10-year DSS probabilities for AGC patients. Validation revealed that this nomogram exhibited excellent discrimination and calibration capacity, suggesting its clinical utility.